Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Loss and Comprehensive Loss (Unaudited)

v3.21.2
Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
EXPENSES        
Research and development $ 9,227 $ 1,103 $ 14,869 $ 2,644
General and administrative 2,075 1,815 4,417 3,631
Total operating expenses 11,302 2,918 19,286 6,275
OTHER INCOME (EXPENSE)        
Interest income 3 3 11 45
Other expenses (12) (7) (35) (12)
Total other income (expense) (9) (4) (24) 33
Net loss and comprehensive loss $ (11,311) $ (2,922) $ (19,310) $ (6,242)
Basic and diluted net loss per common share $ (1.53) $ (1.68) $ (2.85) $ (3.79)
Weighted average shares used in computation of basic and diluted net loss per common share 7,390,600 1,744,014 6,764,688 1,645,426